OPEN
Emerging Microbes and Infections (2015) 4, e17; doi:10.1038/emi.2015.17 ß 2015 SSCC. All rights reserved 2222-1751/15 www.nature.com/emi
CORRIGENDUM
Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains Huayong Liu1,*, Yanfeng Zhao2,*, Dan Zhao3,*, Ting Gong1, Youcong Wu1, Haiyan Han1, Tao Xu1, Andreas Peschel4, Shiqing Han3 and Di Qu1 Emerging Microbes and Infections (2015) 4, e17; doi:10.1038/emi.2015.17; published online 11 March 2015 Corrigendum to: Emerging Microbes and Infections (2015) 4, e1; doi:10.1038/emi.2015.1; published online 7 January 2015 The authors apologized for an error in the second affiliation. The original affiliation ‘‘Department of Laboratory Medicine, Affiliated Gulou Hospital, Medical College of Nanjing University, Nanjing 210008, Jiangsu, China’’ should be changed to: ‘‘Department of Laboratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, China’’.
1 Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institute of Medical Microbiology and Institutes of Biomedical Sciences, Shanghai Medical, College of Fudan University, Shanghai 200032, China; 2Department of Laboratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, China; 3College of Biotechnology and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing 210009, Jiangsu, China and 4Cellular and Molecular, Microbiology Division, Interfaculty Institute of Microbiology and Infection Medicine, University of Tu¨bingen, Tu¨bingen 72076, Germany *These authors contributed equally to this work. Correspondence: SQ Han; D QU E-mail: [email protected]; [email protected] Received 3 June 2014; revised 26 October 2014; accepted 24 November 2014
Emerging Microbes and Infections (2015) 4, e17; doi:10.1038/emi.2015.17 ß 2015 SSCC. All rights reserved 2222-1751/15 www.nature.com/emi
CORRIGENDUM
Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains Huayong Liu1,*, Yanfeng Zhao2,*, Dan Zhao3,*, Ting Gong1, Youcong Wu1, Haiyan Han1, Tao Xu1, Andreas Peschel4, Shiqing Han3 and Di Qu1 Emerging Microbes and Infections (2015) 4, e17; doi:10.1038/emi.2015.17; published online 11 March 2015 Corrigendum to: Emerging Microbes and Infections (2015) 4, e1; doi:10.1038/emi.2015.1; published online 7 January 2015 The authors apologized for an error in the second affiliation. The original affiliation ‘‘Department of Laboratory Medicine, Affiliated Gulou Hospital, Medical College of Nanjing University, Nanjing 210008, Jiangsu, China’’ should be changed to: ‘‘Department of Laboratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, China’’.
1 Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institute of Medical Microbiology and Institutes of Biomedical Sciences, Shanghai Medical, College of Fudan University, Shanghai 200032, China; 2Department of Laboratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, China; 3College of Biotechnology and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing 210009, Jiangsu, China and 4Cellular and Molecular, Microbiology Division, Interfaculty Institute of Microbiology and Infection Medicine, University of Tu¨bingen, Tu¨bingen 72076, Germany *These authors contributed equally to this work. Correspondence: SQ Han; D QU E-mail: [email protected]; [email protected] Received 3 June 2014; revised 26 October 2014; accepted 24 November 2014
